IRCT20200803048281N1招募中3 期
The evaluation of pathologic complete response and clinical complete response in locally advanced rectal cancer who treated with total neoadjuvant therapy compared with standard treatment
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with pathologically confirmed rectal cancer who are in locally advanced stage based on imaging
排除标准
- •Patients diagnosed with Renal disease who are not candidates for chemotherapy or need to adjust the dose
- •Patients diagnosed with hepatic disease who are not candidates for chemotherapy or need to adjust the dose
- •Patients diagnosed with Cardiovascular disease who are not candidates for chemotherapy
- •Patients with underlying colorectal disease such as Crohn's disease or ulcerative collitis
研究者
相似试验
进行中（未招募）
1 期
DRelapsing Remitting Multiple SclerosisMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-000708-26-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE50
进行中（未招募）
不适用
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CR-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialEUCTR2005-005139-84-ATPIERRE FABRE MEDICAMENT200
进行中（未招募）
不适用
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CT-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialocally advanced non small cell lung cancerEUCTR2005-005139-84-CZPIERRE FABRE MEDICAMENT200
进行中（未招募）
1 期
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CT-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialocally advanced non small cell lung cancerMedDRA version: 8.1Level: LLTClassification code 10025044Term: Lung cancerEUCTR2005-005139-84-FIPIERRE FABRE MEDICAMENT200
进行中（未招募）
1 期
Assessment of combination chemotherapy in colorectal cancer patients with peritoneal metastases by analysing obtained tumor tissue samples (CARCINOSIS).EUCTR2015-002917-30-ATMedical University of Vienna50